关注
Stephanie Reuter Lange
Stephanie Reuter Lange
在 unisa.edu.au 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Carnitine and acylcarnitines: Pharmacokinetic, pharmacological and clinical aspects
SE Reuter, AM Evans
Clinical pharmacokinetics 51 (9), 553-572, 2012
4602012
Reliability and validity of indices of hand‐grip strength and endurance
SE Reuter, N Massy‐Westropp, AM Evans
Australian occupational therapy journal 58 (2), 82-87, 2011
862011
Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease
AM Evans, RJ Faull, RL Nation, S Prasad, T Elias, SE Reuter, G Fornasini
Kidney international 66 (4), 1527-1534, 2004
792004
Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients
SE Reuter, RJ Faull, E Ranieri, AM Evans
Nephrology Dialysis Transplantation 24 (3), 990-996, 2009
642009
Determination of the reference range of endogenous plasma carnitines in healthy adults
SE Reuter, AM Evans, DH Chace, G Fornasini
Annals of clinical biochemistry 45 (6), 585-592, 2008
572008
A retrospective study to determine the cefepime-induced neurotoxicity threshold in hospitalized patients
C Lau, D Marriott, M Gould, D Andresen, SE Reuter, J Penm
Journal of Antimicrobial Chemotherapy 75 (3), 718-725, 2020
552020
Pharmacokinetics of cannabis in cancer cachexia-anorexia syndrome
SE Reuter, JH Martin
Clinical pharmacokinetics 55, 807-812, 2016
552016
L‐carnitine supplementation in the dialysis population: Are Australian patients missing out?
SE Reuter, RJ Faull, AM Evans
Nephrology 13 (1), 3-16, 2008
512008
Long‐chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase‐I activity
SE Reuter, AM Evans
Journal of internal medicine 270 (1), 76-84, 2011
472011
Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease
SE Reuter, AM Evans, RJ Faull, DH Chace, G Fornasini
Annals of clinical biochemistry 42 (5), 387-393, 2005
382005
Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology
BD Menz, SL Stocker, N Verougstraete, D Kocic, P Galettis, CP Stove, ...
British Journal of Clinical Pharmacology 87 (2), 227-236, 2021
322021
Pharmacokinetics of a transdermal testosterone cream in healthy postmenopausal women
E Fooladi, SE Reuter, RJ Bell, PJ Robinson, SR Davis
Menopause 22 (1), 44-49, 2015
282015
Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin
SE Reuter, AM Evans, S Shakib, Y Lungershausen, B Francis, G Valentini, ...
Clinical drug investigation 35, 559-567, 2015
272015
Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposure
RV Shingde, SE Reuter, GG Graham, JE Carland, KM Williams, RO Day, ...
Journal of Antimicrobial Chemotherapy 75 (11), 3293-3302, 2020
212020
Evaluation of a pilot vancomycin precision dosing advisory service on target exposure attainment using an interrupted time series analysis
SL Stocker, JE Carland, SE Reuter, AE Stacy, AL Schaffer, M Stefani, ...
Clinical Pharmacology & Therapeutics 109 (1), 212-221, 2021
192021
Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria
SE Reuter, RN Upton, AM Evans, V Navaratnam, PL Olliaro
Journal of Antimicrobial Chemotherapy 70 (3), 868-876, 2015
192015
Cannabinoid disposition after human intraperitoneal use: an insight into intraperitoneal pharmacokinetic properties in metastatic cancer
CJ Lucas, P Galettis, S Song, N Solowij, SE Reuter, J Schneider, ...
Clinical therapeutics 40 (9), 1442-1447, 2018
162018
Comparison of the area under the curve for vancomycin estimated using compartmental and noncompartmental methods in adult patients with normal renal function
RV Shingde, GG Graham, SE Reuter, JE Carland, RO Day, SL Stocker
Therapeutic drug monitoring 41 (6), 726-731, 2019
142019
Pharmacokinetics and comparative bioavailability of artesunate and mefloquine administered separately or as a fixed combination product to healthy volunteers and patients with …
P Olliaro, S Ramanathan, M Vaillant, SE Reuter, AM Evans, S Krudsood, ...
J Bioequiv Availab 2 (3), 59-66, 2010
132010
Accuracy of documented administration times for intravenous antimicrobial drugs and impact on dosing decisions
SA Roydhouse, JE Carland, DS Debono, MT Baysari, SE Reuter, ...
British journal of clinical pharmacology 87 (11), 4273-4282, 2021
122021
系统目前无法执行此操作,请稍后再试。
文章 1–20